-
公开(公告)号：US20220152014A1
公开(公告)日：2022-05-19
申请号：US17508267
申请日：2021-10-22
Applicant: Gilead Sciences, Inc.
Inventor： Peter A. Blomgren , Taryn Campbell , Jayaraman Chandrasekhar , Christopher T. Clark , Julian A. Codelli , Kevin S. Currie , Jeffrey E. Kropf , Yasamin Moazami , Nicole Nava , Leena Patel , Stephane Perreault , Jason K. Perry , Kassandra F. Sedillo , Natalie Seeger , Kirk L. Stevens , Jennifer Anne Treiberg , Suet C. Yeung , Zhongdong Zhao
IPC: A61K31/47 , A61K31/352 , A61K31/4709 , A61K31/497 , A61K31/501 , A61K31/513 , A61K31/5377 , A61K31/541 , C07D215/14 , C07D311/58 , C07D401/10 , C07D403/10 , C07D405/10 , C07D413/12 , C07D413/14 , C07D417/10 , C07D471/04 , C07D519/00
Abstract: The present disclosure provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.
-
公开(公告)号：US20200163953A1
公开(公告)日：2020-05-28
申请号：US16667572
申请日：2019-10-29
Applicant: Gilead Sciences, Inc.
Inventor： Peter A. Blomgren , Taryn Campbell , Jayaraman Chandrasekhar , Christopher T. Clark , Julian A. Codelli , Kevin S. Currie , Jeffrey E. Kropf , Yasamin Moazami , Nicole Nava , Leena Patel , Stephane Perreault , Jason K. Perry , Kassandra F. Sedillo , Natalie Seeger , Kirk L. Stevens , Jennifer Anne Treiberg , Suet C. Yeung , Zhongdong Zhao
IPC: A61K31/47 , A61K31/541 , C07D215/14 , C07D413/12 , A61K31/5377 , A61K31/513 , C07D401/10 , A61K31/4709 , C07D417/10 , C07D403/10 , A61K31/497 , A61K31/501 , C07D405/10 , C07D413/14 , C07D471/04 , C07D519/00 , C07D311/58 , A61K31/352
Abstract: The present disclosure provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.
-
公开(公告)号：US20220226337A1
公开(公告)日：2022-07-21
申请号：US17550591
申请日：2021-12-14
Applicant: Gilead Sciences, Inc.
Inventor： Peter A. Blomgren , Taryn Campbell , Jayaraman Chandrasekhar , Christopher T. Clark , Julian A. Codelli , Kevin S. Currie , Jeffrey E. Kropf , Yasamin Moazami , Nicole Nava , Leena Patel , Stephane Perreault , Jason K. Perry , Kassandra F. Sedillo , Natalie Seeger , Kirk L. Stevens , Jennifer Anne Treiberg , Suet C. Yeung , Zhongdong Zhao
IPC: A61K31/5377 , A61K31/343 , A61K31/353 , A61K31/357 , A61K31/416 , A61K31/4375 , A61K31/4709 , A61K31/513 , A61K31/519 , A61K31/538 , A61K31/541 , A61K45/06 , C07D295/00 , C07D307/87 , C07D319/18 , C07D405/10 , C07D407/10 , C07D413/14 , C07D471/04
Abstract: The present disclosure provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.
-
公开(公告)号：US20200155563A1
公开(公告)日：2020-05-21
申请号：US16667373
申请日：2019-10-29
Applicant: Gilead Sciences, Inc.
Inventor： Peter A. Blomgren , Taryn Campbell , Jayaraman Chandrasekhar , Christopher T. Clark , Julian A. Codelli , Kevin S. Currie , Jeffrey E. Kropf , Yasamin Moazami , Nicole Nava , Leena Patel , Stephane Perreault , Jason K. Perry , Kassandra F. Sedillo , Natalie Seeger , Kirk L. Stevens , Jennifer Anne Treiberg , Suet C. Yeung , Zhongdong Zhao
IPC: A61K31/5377 , A61K31/541 , A61K45/06 , C07D405/10 , A61K31/4709 , A61K31/357 , C07D319/18 , C07D413/14 , A61K31/513 , C07D307/87 , A61K31/343 , C07D295/00 , A61K31/538 , C07D407/10 , A61K31/353 , A61K31/416 , C07D471/04 , A61K31/4375 , A61K31/519
Abstract: The present disclosure provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.
-
公开(公告)号：US20200155538A1
公开(公告)日：2020-05-21
申请号：US16667306
申请日：2019-10-29
Applicant: Gilead Sciences, Inc.
Inventor： Peter A. Blomgren , Taryn Campbell , Jayaraman Chandrasekhar , Christopher T. Clark , Julian A. Codelli , Kevin S. Currie , Jeffrey E. Kropf , Yasamin Moazami , Nicole Nava , Leena Patel , Stephane Perreault , Jason K. Perry , Kassandra F. Sedillo , Natalie Seeger , Kirk L. Stevens , Jennifer Anne Treiberg , Suet C. Yeung , Zhongdong Zhao
IPC: A61K31/47 , A61K45/06 , C07D215/14 , C07D401/10 , A61K31/4709 , C07D401/12 , C07D405/14 , C07D409/14 , C07D413/14 , C07D401/14 , C07D407/14 , A61K31/506 , A61K31/501 , A61K31/5355 , C07D413/12 , C07D417/12 , A61K31/541 , A61K31/517 , A61K31/4375 , C07D471/04 , C07D487/04 , A61K31/519
Abstract: The present disclosure provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.
-
Patent Agency Ranking
公开(公告)号：US20250042915A1
公开(公告)日：2025-02-06
申请号：US18743475
申请日：2024-06-14
Applicant: Gilead Sciences, Inc.
Inventor： Stephen E. Ammann , Xinpei Cai , Eda Y. Canales , Weng K. Chang , Gregory F. Chin , Henok H. Kinfe , Scott E. Lazerwith , Jessica L. McKinley , Michael R. Mish , Devan Naduthambi , Jason K. Perry , Kevin X. Rodriguez , Scott D. Schroeder , Christopher J. Swank , Joshua J. Van Veldhuizen
IPC: C07D495/04 , A61P31/14 , C07D401/04 , C07D401/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D487/10 , C07D491/107 , C07D491/113 , C07D498/04 , C07D513/04 , C07D519/00
Abstract: The present disclosure relates to compounds of Formula I: and pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, useful in the treatment of treating viral infections, for example, coronaviridae infections.
-
公开(公告)号：US20240116946A1
公开(公告)日：2024-04-11
申请号：US18376159
申请日：2023-10-03
Applicant: Gilead Sciences, Inc.
Inventor： Stephen E. Ammann , Xinpei Cai , Eda Y. Canales , Weng K. Chang , Gregory F. Chin , Henok H. Kinfe , Scott E. Lazerwith , Jessica L. McKinley , Michael R. Mish , Devan Naduthambi , Jason K. Perry , Kevin X. Rodriguez , Scott D. Schroeder , Christopher J. Swank , Joshua J. Van Veldhuizen
IPC: C07D495/04 , C07D401/04 , C07D519/00
CPC classification number: C07D495/04 , C07D401/04 , C07D519/00
Abstract: The present disclosure relates to compounds of Formula I:
and pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, useful in the treatment of treating viral infections, for example, coronaviridae infections.-
公开(公告)号：US20230041518A1
公开(公告)日：2023-02-09
申请号：US17379175
申请日：2021-07-19
Applicant: Gilead Sciences, Inc.
Inventor： Peter A. Blomgren , Taryn Campbell , Jayaraman Chandrasekhar , Christopher T. Clark , Julian A. Codelli , Kevin S. Currie , Jeffrey E. Kropf , Yasamin Moazami , Nicole Nava , Leena Patel , Stephane Perreault , Jason K. Perry , Kassandra F. Sedillo , Natalie Seeger , Kirk L. Stevens , Jennifer Anne Treiberg , Suet C. Yeung , Zhongdong Zhao
IPC: A61K31/47 , A61K31/4375 , A61K31/4709 , A61K31/501 , A61K31/506 , A61K31/517 , A61K31/519 , A61K31/5355 , A61K31/541 , A61K45/06 , C07D215/14 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/14 , C07D407/14 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/12 , C07D471/04 , C07D487/04
Abstract: The present disclosure provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.
-
公开(公告)号：US11116760B2
公开(公告)日：2021-09-14
申请号：US16667306
申请日：2019-10-29
Applicant: Gilead Sciences, Inc.
Inventor： Peter A. Blomgren , Taryn Campbell , Jayaraman Chandrasekhar , Christopher T. Clark , Julian A. Codelli , Kevin S. Currie , Jeffrey E. Kropf , Yasamin Moazami , Nicole Nava , Leena Patel , Stephane Perreault , Jason K. Perry , Kassandra F. Sedillo , Natalie Seeger , Kirk L. Stevens , Jennifer Anne Treiberg , Suet C. Yeung , Zhongdong Zhao
IPC: C07D413/14 , A61K31/5377 , A61K31/47 , A61K31/4375 , A61K31/4709 , A61K31/501 , A61K31/506 , A61K31/517 , A61K31/519 , A61K31/5355 , A61K31/541 , A61K45/06 , C07D215/14 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/14 , C07D407/14 , C07D409/14 , C07D413/12 , C07D417/12 , C07D471/04 , C07D487/04
Abstract: The present disclosure provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.
-
公开(公告)号：US20250032473A1
公开(公告)日：2025-01-30
申请号：US18740078
申请日：2024-06-11
Applicant: Gilead Sciences, Inc.
Inventor： Peter A. Blomgren , Taryn Campbell , Jayaraman Chandrasekhar , Christopher T. Clark , Julian A. Codelli , Kevin S. Currie , Jeffrey E. Kropf , Yasamin Moazami , Nicole Nava , Leena Patel , Stephane Perreault , Jason K. Perry , Kassandra F. Sedillo , Natalie Seeger , Kirk L. Stevens , Jennifer Anne Treiberg , Suet C. Yeung , Zhongdong Zhao
IPC: A61K31/47 , A61K31/4375 , A61K31/4709 , A61K31/501 , A61K31/506 , A61K31/517 , A61K31/519 , A61K31/5355 , A61K31/541 , A61K45/06 , C07D215/14 , C07D215/18 , C07D401/04 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/14 , C07D407/14 , C07D409/14 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D471/04 , C07D475/02 , C07D487/04 , C07D491/04 , C07D491/06 , C07D491/08 , C07D498/10 , C07D513/04
Abstract: The present disclosure provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.
-
-
-
-
-
-
-
-
-
Search Results
21
records
(took 0.011 seconds)
